Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.

John Varga*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)145-146
Number of pages2
JournalCurrent Rheumatology Reports
Volume5
Issue number2
DOIs
StatePublished - Jan 1 2003

ASJC Scopus subject areas

  • Rheumatology

Cite this